CD206 was highly expressed with significance in active BD patients with cutaneous symptoms (49.7 ± 35.2%) compared to inactive BD patients (4.7 ± 3.1%) (p = 0.007) and HCs (7.4 ± 0.8%) (p = 0.02). The gene discussed is MRC1; the disease is Behcet disease.